相关实验视频
Updated: Jan 17, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
黑色素瘤的演变,这种黑色素瘤逃脱了全基因排斥
Ahmed Rokan1, Mariana O Diniz2, Jose I de Las Heras3
1Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia; Division of Infection & Immunity and Institute of Immunity and Transplantation, The Pears Building, University College London, Pond Street, London NW3 2PP, UK.
Cell reports
|September 14, 2025
概括
癌细胞可以通过发展与可逆转移元素相关的抗病毒特征来进化以逃避免疫排斥. 这种适应性使瘤对免疫检查点阻断疗法敏感,为治疗提供了新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 基因相容性屏障通常会阻止个体之间的细胞转移.
- 在某些物种中,可传播的癌症证明了这一障碍的例外.
- 了解癌症免疫逃生机制对于开发有效疗法至关重要.
研究的目的:
- 为了研究癌细胞是否可以进化以克服基因相容性障碍.
- 确定使瘤细胞从异构排斥中逃脱的分子机制.
- 探索潜在的治疗目标,以克服免疫逃避.
主要方法:
- 鼠标黑色素瘤在不匹配的鼠标菌株之间连续传递.
- 进化移植性瘤细胞中的分子变化的分析.
- 基因淘汰研究 (RIG-I) 和抗体介导阻断 (PD-L1,Qa-1).
主要成果:
- 进化的黑色素瘤细胞表现出抗病毒免疫特征和上调的内源逆转移元素 (RTEs).
- 观察到主要基因相容性复合物I类 (MHC I类),PD-L1和Qa-1分子的升级.
- RIG-I的淘汰减少了PD-L1和Qa-1的表达;这些分子的阻断诱导了瘤排斥.
- 在响应PD-L1阻塞的人类黑色素瘤中发现了类似的免疫特征.
结论:
- 与RTEs上调相关的免疫抗病毒特征,有助于黑色素瘤从异性排斥中逃脱.
- 这种适应使瘤易受PD-L1和Qa-1对抗.
- 研究结果表明,针对这些途径进行癌症治疗的潜在治疗策略.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell
14.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Mismatch Repair
6.3K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.3K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

